Evaluation of dexmedetomidine: Safety and clinical outcomes in critically Ill trauma patients

Journal of Trauma - Injury, Infection and Critical Care

Volumn 71, Issue 5, 2011, Pages 1164-1171

  Devabhakthuni, Sandeep ^a   Pajoumand, Mehrnaz ^b   Williams, Carla ^b   Kufera, Joseph A ^c   Watson, Kristin ^d   Stein, Deborah M ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Critical care; Dexmedetomidine; Propofol; Sedation; Trauma

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTIHYPERTENSIVE AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DEXMEDETOMIDINE; DIAZEPAM; FENTANYL; HALOPERIDOL; HYPERTENSIVE AGENT; LORAZEPAM; MIDAZOLAM; MORPHINE; NEUROLEPTIC AGENT; OLANZAPINE; OXYCODONE; PROPOFOL; SEDATIVE AGENT; ZIPRASIDONE;

ABDOMINAL INJURY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BLUNT TRAUMA; BRADYCARDIA; BRAIN INJURY; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART RATE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; INJURY; INTENSIVE CARE UNIT; LENGTH OF STAY; LIMB INJURY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEDATION; SPINAL CORD INJURY; SUBSTANCE ABUSE; TACHYCARDIA; TREATMENT OUTCOME;

ADULT; ANALGESICS; ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; CRITICAL ILLNESS; DEXMEDETOMIDINE; ENDPOINT DETERMINATION; FEMALE; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTENSION; INFUSIONS, INTRAVENOUS; LENGTH OF STAY; MALE; MIDDLE AGED; PROPOFOL; REGISTRIES; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TIME FACTORS; WOUNDS AND INJURIES;

EID: 81455133654     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3182147670     Document Type: Article

References (22)

1. Jacobi J, Fraser GL, Coursin DB, et al. Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119-141. (Pubitemid 34112188)
2. Riker RR, Fraser GL. Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy. 2005;25:8s-18s. (Pubitemid 40604874)
3. Kolleff MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998;114:541-548. (Pubitemid 28387536)
4. Pandharipande P, Ely EW. Sedative and analgesic medications: risk factors for delirium and sleep disturbances in the critically ill. Crit Care Clin. 2006;22:313-327.
5. Maze M, Scarfinin C, Cavaliere F. New agents for sedation in the intensive care unit. Crit Care Clin. 2001;17:881-897. (Pubitemid 33101686)
6. Chiu TH, Chen MJ, Yang YR, Yang JJ, Tang FI. Action of dexmedetomidine on rat locus coeruleus neurons: intracellular recording in vitro. Eur J Pharmacol. 1995;285:261-268.
7. Product information. Precedex (Dexmedetomidine). Lake Forest, IL: Hospira; 2008.
8. Bhana N, Goa KL, McClellan K. Dexmedetomidine. Drugs. 2000;59: 263-268.
9. Szumita PM, Baroletti SA, Anger KE, Wechsler ME. Sedation and analgesia in the intensive care unit: evaluation of the role of dexmedetomidine. Am J Health Syst Pharm. 2007;64:37-44. (Pubitemid 46395706)
10. Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med. 2004;30:2188-2196. (Pubitemid 40174254)
11. Corbett SM, Rebuck JA, Greene CM, et al. Dexmedetomidine does not improve patient satisfaction when compared to propofol during mechanical ventilation. Crit Care Med. 2005;33:940-945. (Pubitemid 40638161)
12. Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothor Vasc Anesth. 2003;17:576-584. (Pubitemid 37296621)
13. Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth. 2001;87:684-690. (Pubitemid 33069556)
14. Elbaradie S, El Mahalawy FH, Solyman AH. Dexmedetomidine vs. propofol for short-term sedation of postoperative mechanically ventilated patients. J Egyptian Nat Cancer Inst. 2004;16:153-158.
15. Pandharipande P, Ely EW, Maze M. Dexmedetomidine for sedation and perioperative management of critically ill patients. Semin Anesth Periop Med Pain. 2006;25:43-50. (Pubitemid 43833199)
16. Venn RM, Newmann PJ, Grounds RM. A phase II study to evaluate efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med. 2003;29:201-207. (Pubitemid 36384409)
17. Pandharipande P, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs. lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS Randomized Controlled Trial. JAMA. 2007;298:2644-2653. (Pubitemid 350254956)
18. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs. midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301:489-499.
19. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors, and consequences of ICU delirium. Intensive Care Med. 2007; 32:2254-2259.
20. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291:1753-1762. (Pubitemid 38489897)
21. Jackson KC, Godon SM, Girard TD, et al. Delirium as a risk factor for long term cognitive impairment in mechanically ICU survivors [abstract]. Am J Respir Crit Care Med. 2007;1175:A22.
22. Nelson LE, Guo TZ, Lu J, Saper CB, Franks NP, Maze M. The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci. 2002;5:979-984.